In our rural practice (McCreight Progressive Dentistry) in Northwest Colorado, we see periodontal disease on average in about one of every two patients, or around 46%. This is representative of the CDC statistic as posted in the May 2015 Journal of Periodontology. Whenever we read these statistics, we are puzzled. In an industrialized nation where home care tools and dental technologies are readily available, how can there be so much disease? Here are some measures (newer technologies) we have been utilizing for our patients to provide a higher quality of care and reduce the prevalence of periodontal disease. What we are finding is that these measures are being incorporated into our soft tissue program (called the MPDWay™) and are being accepted by our patients, even in a rural setting.
Beginning in 2011, we introduced both PerioProtect® trays (trays with 1.7% hydrogen peroxide gel and low dose doxycycline) and OralDNA® salivary testing as our office standard of care with the goal to provide better, more predictable treatment outcomes. Both work in tandem; OralDNA® is a salivary test to provide quantitative data to help recommend treatment in a more systematic way, and PerioProtect® as a unique tray system to be used at home to decrease pathogen loads (resulting in decreasing inflammation).
We recommend a panel of OralDNA® tests (MyPerioPath®, Celsus One™, OraRisk® HPV and OraRisk® Candida) to all of our patients. But of utmost consideration is to recommend testing to our patients that are showing any signs of inflammation and infection. This allows us to gather as much information and customize our treatment plan on objective data. Knowing in advance the pathogen types, including high risk pathogens as well as gene markers associated with increased inflammation, is simply good medicine. When a well-trained team is armed with the salivary test results, many of our patients choose beyond the level of basic coverage from their respective dental benefit plan. Furthermore, the test reports provide objective information that helps the patient understand and own their disease. We have found these test results produce more case acceptance.
The addition of PerioProtect® into our treatment protocol has also been successful. At first, the trays were recommended by our office to the patient’s home care routine when both electric tooth brushing and oral irrigators were not effective. We now incorporate the use of these trays from the very beginning of treatment, even before active therapy, but ideally not before we perform the OralDNA® (MyPerioPath®) test. The test results before treatment, after treatment and as a monitoring tool helps us confirm the effectiveness of this tray system.
In conclusion, if dental teams continue to focus on bone/tooth loss, tooth mobility, or even simply calculus being present as the entry point to the discussion of periodontal disease, the above CDC statistic won’t change. By incorporating both OralDNA® salivary diagnostics and PerioProtect® trays into the dental office’s respective soft tissue program, you have tools to help produce healthier patients. In summary, a higher quality of care can be provided in rural America.
This blog originally posted 9/8/2017. We hope you enjoyed the holiday throwback.
For more information on how to become an OralDNA Provider – scan HERE:
- A Progressive Oral Wellness Center in Rural America - May 22, 2020
- A Progressive Oral Wellness Center in Rural America - September 8, 2017